HEATHER MARCEE: Open Payments
NPI 1467290510 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 15 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $125 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $266 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $115 |
| Alkermes, Inc. | 1 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $79 |
| ABBVIE INC. | 2 | $36 |
| Corium, LLC | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $24 |
Products named: REXULTI, CAPLYTA, ARISTADA, TRINTELLIX, VRAYLAR, Azstarys, Auvelity.
Industry payments across TX — which companies pay providers there.
